Company intelligence / Profile preview

Nextar Chempharma Solutions

Nes Ziona, Center District, Israelnextar.com ↗

Ownership: Private
Development stage: Other

Overview

Nextar Chempharma Solutions develops and manufactures innovative pharmaceuticals and medical devices, including proprietary technologies for targeted drug delivery. It has contributed to the development of over 150 products (some for itself, some as a CDMO), with global commercialization. The company holds cGMP, GLP, ISO 13485, and ISO 9001 certifications and has been audited by FDA/European bodies.

Modalities: Small moleculeBiologicMedical device
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Nextar Chempharma Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nextar Chempharma Solutions.

Explore the full profile